Insulin, either alone or in combination with other agents, most commonly metformin, is an effective option for restoring normoglycemia, especially when administered early in the disease course. The disadvantages of insulin therapy are weight gain and an increased risk of hypoglycemia. Insulin has not been observed to have clinically relevant effects on either blood pressure or lipids.